Australia: What rights do licensees need in order to have standing to sue for patent infringement? Federal Court clarifies meaning of "exclusive licensee"

The Federal Court has held that a patent licensee will only have standing to bring infringement proceedings under the "exclusive licensee" provisions of the Patents Act 1990 (Cth), if that licensee has been granted all of the rights of the patent holder to exploit the patent, including the right to manufacture the product which is the subject of the patent.

In the recent case of Bristol-Myers Squibb Company v Apotex Pty Ltd (No 5)1, Justice Yates held that if any residual rights are reserved for the patent holder (or any other person) the licence will not be "exclusive" and the licensee will not have standing to sue for infringement.

As a result, careful contractual drafting is required if it is intended that a licensee should have the right to enforce a patent in its own name.


Under the Patents Act, the only persons who are entitled to commence patent infringement proceedings are the patent holder and its exclusive licensee2. Accordingly, whether or not a licence is considered to be "exclusive" has significant implications for both the patent holder and the licensee.

Prior to the decision in Bristol-Myers Squibb Company v Apotex Pty Ltd (No 5), there was some uncertainty as to what rights a licensee must be granted before it will be considered an "exclusive licensee" under the Patents Act.

Earlier cases suggested that a licence could be considered exclusive if it conferred on the licensee (and no one else) some (but not necessarily all) of the rights of the patent holder to "exploit" the patent in the patent area3. This line of reasoning was rejected by Justice Yates in Bristol-Myers Squibb Company v Apotex Pty Ltd (No 5).


Otsuka Pharmaceutical Co Ltd (Otsuka) held an Australian patent for the product (and process for preparing) an improved form of aripipazole, a drug used in the treatment of schizophrenia.

In 2001, Otsuka entered into an agreement with Bristol-Myers Squibb (BMS) under which BMS was granted the exclusive right to advertise, market, promote, distribute and sell aripipazole in every country in the world except the United States and the European Union.

Under the terms of the licence, Otsuka reserved for itself the exclusive, worldwide right to manufacture aripipazole.

In 2009, BMS claimed that Apotex Pty Ltd (Apotex) had infringed or threatened to infringe Otsuka's patent by offering to sell various pharmaceutical products in Australia which contained aripipazole as the active ingredient. BMS commenced proceedings against Apotex, relying on its rights as the exclusive licensee of the patent.

Apotex claimed that, because BMS did not have the right to manufacture aripipazole, BMS was not an "exclusive licensee" under the Patents Act and accordingly did not have standing to bring the proceedings.


Justice Yates agreed with the reasoning put forward by Apotex, finding that, because the licence granted to BMS excluded the right to manufacture aripipazole, BMS could not be an exclusive licensee with standing to sue Apotex for infringement.

His Honour found that, for a licence to be exclusive, the legal effect of the licence must be that the patent holder (and all other persons) are excluded from the exploiting the patent by any means in the patent area.

His Honour stated that, "An exclusive licence cannot be one that reserves to the patentee or any other person any residual right with respect to the exploitation of the invention. It follows that there can only be one exclusive licensee."4


Ultimately, by joining the patentee (Otsuka) to the proceedings, BMS was able to restrain Apotex from selling certain products containing the patented form of aripipazole in Australia.

However, the fact that BMS did not have standing to sue Apotex for infringement meant that BMS was unable to recover any of its costs in relation to the infringement proceedings from Apotex5. In a subsequent decision on costs, Justice Yates held that, "it would be incongruous to award BMS all its costs of the proceeding when, in my view, it had no entitlement to commence or to prosecute its claims for infringement."6


BMS has appealed Justice Yate's findings on standing and costs to the Full Federal Court.


Following the reasoning of Justice Yates, in order for a licence to be exclusive, a licensee must be granted all of the rights of the patent holder to "exploit" the patent in the patent area. The term "exploit" has a specific meaning under the Patents Act.

In order to have all of the rights to "exploit" the patent, a licensee must be granted the exclusive rights:

  • if the patented invention is a product, to make, hire, sell (or otherwise dispose of) the product, offer to make, sell, hire (or otherwise dispose of) it, use and import it and keep it for the purpose of doing any of those things; or
  • if the patented invention is a method or process, to use the method or process or do all of above things in respect of a product resulting from such use.

Essentially, the licensee must step into the shoes of the patent holder with respect to the rights granted by the patent.


In light of this decision (which is subject to appeal):

  • Patent licences under which it is intended that a licensee should have the right to enforce a patent in its own name should be carefully drafted. The Licensee must be granted all of the rights to "exploit" the patent (including the right to import and manufacture the product) if it is to have standing to take action for patent infringement as an exclusive licensee.
  • Even if a licence is not "exclusive" in accordance with the meaning given to this term in this decision, the parties can contractually agree on an approach to commencing patent infringement proceedings. For example, a licensee may be granted the right to commence infringement proceedings in the patentee's name, as its agent. However, the patentee may be reluctant to agree to an agency approach or may wish to impose tight controls on the licensee's appointment as its agent. In addition, if the licensee commences action as agent for the patentee and does not have standing to commence action in its own name, it cannot recover damages for the losses that it has suffered as a result of the infringement (it will only be able to recover the losses suffered by the patentee, which will likely be considerably less than the losses suffered by the licensee).
  • Describing a licence as "exclusive" does not mean that the licensee will necessarily have standing to sue for patent infringement.
  • This decision suggests that multiple "exclusive licensees" cannot exist in the patent area (for example, in relation to different fields of application of the licensed invention). Careful consideration should be given to who will commence and control patent infringement litigation in situations where the patentee has more than one licensee in the patent area.
  • Licensees under an existing licence which does not exclusively confer all of the rights to exploit the patent may wish to consider whether a variation to the licence may need to be agreed with the licensor, if the expectation was that the licensee would be an "exclusive licensee" under the Patents Act.
  • It is open to patentees who have granted an exclusive licence to contractually restrict the licensee from bringing infringement proceedings in its own name. For example, it may be expressly stated in the licence that only the patentee has the right to take any action (including commencing patent infringement proceedings) in relation to the patent in the patent area. It could also be stated in the licence that the licensee has no right to exercise the rights granted to an exclusive licensee under the Patents Act.

We await the hearing of the appeal in this matter and will report in due course on the outcome of the appeal.

1[2013] FCA 1114.

2See section 120(1) of the Patents Act 1990 (Cth).

3See for example Grant v Australian Temporary Fencing Pty Ltd (2003) 59 IPR 170.

4At [435].

5Bristol Myers Squibb Company v Apotex (No 6) [2013] FCA 1235.

6Bristol Myers Squibb Company v Apotex (No 6) [2013] FCA 1235 at [9].

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Most awarded firm and Australian deal of the year
Australasian Legal Business Awards
Employer of Choice for Women
Equal Opportunity for Women
in the Workplace (EOWA)

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Mondaq Advice Centre (MACs)
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.